Immunotherapy: Esophageal And Gastric Cancer

Immunotherapy: esophageal and gastric cancer

Dr. Janjigian on Immunotherapy in Esophageal and Gastric Cancer

Dr. Ku on Immunotherapy for Gastric and Esophageal Cancer

Gastroesophageal Cancer: Current Positioning of Immunotherapy

The role of neoadjuvant immunotherapy in MSI-high gastric cancer

PD-1 and PD-L1 Expression in Esophageal and Gastric Cancer

Targeted Oncology

Immunotherapy Management of Early and Advanced Gastric, Esophageal, GEJ, and Colorectal Cancers

PeerView Oncology

Check-Point Inhibitors in Esophageal and Gastric Cancer: When and for Whom?

Harnessing the Immune System for the Treatment of Gastric and Esophageal Cancer | Harry Yoon, MD

Total Health | Oncology

Dr. Arkenau on the Potential of Immunotherapy in Gastric Cancer

Immunotherapy for Gastroesophageal Cancer

Debbie's Dream Foundation: Curing Stomach Cancer

Dr. Janjigian on Immunotherapy Combinations in Gastric Cancer

Management of Esophageal/GEJ Cancers: An Interdisciplinary Tumor Board on Adjuvant Immunotherapy

PeerView Oncology

MSI Testing’s Impact on Immunotherapy in Gastric Cancers

Expert Video Report on immunotherapy in gastro oesophageal cancer from 2021 ASCO Annual Meeting

European Society for Medical Oncology (ESMO)

Role of Immunotherapy in Gastric Cancers

Targeted Oncology

ESMO 2020 Expert Video Report on 1st line ICI for gastro oesophageal cancer

European Society for Medical Oncology (ESMO)

Navigating Multidisciplinary Care With Immunotherapy in Esophageal/GEJ Cancer

PeerView Oncology

Dr. Yoon on Immunotherapy in Gastric Cancer

Genomic landscape of late-stage gastric cancer treated with pembrolizumab